company

AKER OG ULLEVÅL DIABETES FORSKNINGS FOND

Return on Equity
−16,91 %
Current Ratio
N/A
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue−3 278 000
Net Income−3 878 000
Total Assets22 936 000
Total Equity22 936 000
Income (NOK)2022
Revenue−3 278 000
Expenditure71 000
Operating Profit−3 348 000
Financial Income0
Financial Costs530 000
Financial Balance−530 000
Earnings Before Tax−3 878 000
Tax0
Net Income−3 878 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets22 936 000
Total Assets22 936 000
Total Retained Equity18 154 000
Total Equity22 936 000
Total Long-Term Debt0
Total Current Debt0
Total Equity and Debt22 936 000
Cash flow (NOK)2022
Sales Income0
Other Income−3 278 000
Revenue−3 278 000
Cost of Goods Sold0
Salary Costs59 000
Depreciation0
Impairment0
Expenditure71 000
Operating Profit−3 348 000
Financial Income0
Financial Costs530 000
Financial Balance−530 000
Dividends0
Net Income−3 878 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments22 821 000
Cash, Bank115 000
Total Current Assets22 936 000
Total Assets22 936 000
Total Equity22 936 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt0
Total Equity and Debt22 936 000
Financial indicators2022
Return on Equity−16,91 %
Debt-to-Equity Ratio0
Operating Profit Margin102,14 %
Current Ratio-
Quick Ratio-
Equity Ratio1
Gross Profit Margin100 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English